Migration of dendritic cell based cancer vaccines: in vivo veritas?

This publication has 39 references indexed in Scilit:

• Retinoic Acid: An Educational “Vitamin Elixir” for Gut-Seeking T Cells
  Immunity, 2004
• Regulation of Dendritic Cell Migration to the Draining Lymph Node
  The Journal of Experimental Medicine, 2003
• Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells
  Blood, 2003
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
  The Journal of Experimental Medicine, 2002
• A mouse Ckappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation
  International Immunology, 2002
• Accumulation of Immature Langerhans Cells in Human Lymph Nodes Draining Chronically Inflamed Skin
  The Journal of Experimental Medicine, 2002
• A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
  International Journal of Cancer, 2001
• Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
  The Journal of Experimental Medicine, 2000
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994